Under-the-Radar AI-Driven Biotech to Surge Higher

Emerging AI-Driven Biotech Sybleu, Inc. (OTC:SYBE) offers competitive advantages and upcoming milestones in the stock market's top-followed and funded segment, AI, prompting a potential surge in the stock price.

Read more...
 
TRNR: High Growth, Low Valuation Stock Offers Major Upside

Interactive Strength, Inc. (NASDAQ: TRNR) d/b/a FORME is about to make a profound change in its business that will prompt major growth, accelerate profit, and drive the artificially low valuation substantially higher.

Read more...
 
HLCO: A Burgeoning Health & Wellness Unicorn

Leveraging a $150M M&A-targeted credit facility, and a core relationship with Deepak Chopra, integrated health firm The Healing Company, Inc. (OTCQB: HLCO) is poised to record exponential revenue growth.

Read more...
 
Newly Public MedTech Player in Underserved Market Set for Exponential Growth
Fresh off a successful IPO, NeurAxis Inc. (NYSE Amer: NRXS) is in the role of first mover with an FDA-cleared product in a huge market opportunity.
Read more...
 
New Name, New Initiatives for SDOT
New is a good thing. Sadot Group, Inc. (NASDAQ: SDOT) is the new name and symbol for Muscle Maker, Inc. (NASDAQ: GRIL) and its new initiatives will drive revenue and income growth.
Read more...
 
AccuStem: A Novel Cancer Diagnostics Acquisition Candidate

AccuStem Sciences, Inc. (OTCQB: ACUT) is revolutionizing cancer diagnostics and appears to be a strong acquisition candidate.

Read more...
 
Innovative BioPharma Set for Major Re-Valuation in 2023

OKYO Pharma Limited (NASDAQ: OKYO) just commenced a Phase II clinical trial and with top-line data to be published by year-end, this catalyst could prompt a major re-valuation of the stock.

Read more...
 
Transformed GRIL Set for Record Growth

Muscle Maker, Inc. (NASDAQ: GRIL) is set to grow revenue from $162M in 2022 to over $1B in 2024, with a substantial rise in adjusted net income, thereby driving its share price to new highs

Read more...
 
Undervalued, Underfollowed, High Growth MedTech Firm Offers Major Upside

In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

Read more...
 
This 41% CAGR Stock Set for New Highs

Charlie's Holdings, Inc. (OTCQB: CHUC), a leader in its underlying space appear set to hit new highs as it generates huge sales growth, leverages industry trends, trades at a discount to its peer group, will be up-listing to a national exchange, and benefits from investors finally focusing on current trends and successes instead of only a potential home run scenario.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 47